n-methyl-3,4-methylenedioxyamphetamine has been researched along with am 251 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiranita, T; Nawata, Y; Yamamoto, T | 1 |
| Touriño, C; Valverde, O; Zimmer, A | 1 |
| Kitaichi, K; Nawata, Y; Yamamoto, T | 1 |
3 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and am 251
| Article | Year |
|---|---|
A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Gene Expression Regulation; Hallucinogens; Hippocampus; Male; Memory Disorders; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recognition, Psychology; Substance Withdrawal Syndrome; Time Factors | 2010 |
THC Prevents MDMA Neurotoxicity in Mice.
Topics: Animals; Astrocytes; Body Temperature; Dronabinol; Fever; Hallucinogens; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Piperidines; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Temperature | 2010 |
Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
Topics: Amphetamine-Related Disorders; Animals; Cannabinoid Receptor Antagonists; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Self Administration | 2016 |